Effects of intra-articular hylan G-F 20 injections on clinical and biomechanical characteristics of the knee in osteoarthritis

International Journal of Rehabilitation Research

Volumn 28, Issue 4, 2005, Pages 371-374

  Yavuzer, Güneş ^a,b   Sonel, Birkan ^a   Süldür, Nurben ^a   Ergin, Süreyya ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Mustafa Kemal Mahallesi   (Turkey)

Author keywords

Biomechanics; Gait analysis; Hylan G F 20; Knee; Osteoarthritis; WOMAC

Indexed keywords

BIOMECHANICS; CLINICAL LABORATORIES; DISEASE CONTROL; GAIT ANALYSIS; HOSPITALS; JOINT PROSTHESES; PATIENT REHABILITATION; PATIENT TREATMENT;

HYLAN G-F 20; KNEES; OSTEOARTHRITIS; WOMAC;

MEDICAL APPLICATIONS;

HYALURONIC ACID; DRUG DERIVATIVE; HYLAN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BIOMECHANICS; CLINICAL ARTICLE; FEMALE; GAIT; HUMAN; JOINT MOBILITY; JOINT STIFFNESS; KNEE ARTHRITIS; KNEE OSTEOARTHRITIS; LEG MOVEMENT; LOADING TEST; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; WALKING SPEED; WESTERN ONTARIO MACMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; CLINICAL TRIAL; DRUG EFFECT; HEALTH STATUS; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY;

AGED; BIOMECHANICS; FEMALE; GAIT; HEALTH STATUS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 33645879537     PISSN: 03425282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004356-200512000-00013     Document Type: Article

References (23)

1. Altman RD, Asch E, Bloch DA, Bole GG, Brandt KD, Christy W, et al. (1986). Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039-1049.
2. Aviad A, Houpt JB (1994). The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol 21:297-301.
3. Balazs EA, Denlinger JL (1993). Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20 (Suppl 39):3-9.
4. Bellamy N (1993). Musculoskeletal clinical metrology. Lancaster: Kluwer.
5. Carlson WE, Vaughan CL, Damiano DL, Abel MF (1997). Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil 76:219-225.
6. Crenshaw SJ, Pollo FE, Ericka FC (2000). Effects of lateral-wedged insoles on kinetics at the knee. Clin Orthop Related Res 375:185-192.
7. De Quervain IA, Simon SR, Leurgans S, Pease WS, McAllister D (1996). Gait pattern in the early recovery period after stroke. J Bone Joint Surg 78:1506-1514.
8. Goh JCH, Mech MI, Bose K, Khoo BC (1993). Gait analysis study on patients with varus osteoarthrosis of the knee. Clin Orthop Related Res 294:223-231.
9. Goorman SD, Watanabe TK, Miller EH, Perry C (2000). Functional outcome in knee osteoarthritis after treatment with Hylan G-F: a prospective study. Arch Phys Med Rehabil 81:479-483.
10. Hochberg MC (2000). Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthritis Rheum 30:2-10.
11. Hochberg MC, Altman R, Brandt K, Clark B, Dieppe P, Griffin M, et al. (1995). Guidelines for the medical management of osteoarthritis: part II. Osteoarthritis of the knee. Arthritis Rheum 38:1541-1546.
12. Hurwitz DE, Ryals AR, Block JA, Sharma L, Schnitzer TJ, Andriacchi TP (2000). Knee pain and joint loading in subjects with osteoarthritis of the knee. J Orthop Res 18:572-579.
13. Kaufman KR, Hughes C, Morrey BF, Morrey M, An KN (2001). Gait characteristics of patients with knee osteoarthritis. J Biomech 34:907-915.
14. Kerrigan DC, Riley PO, Nieto TJ, Croce UD (2000). Knee joint torques: a comparison between women and men during barefoot walking. Arch Phys Med Rehabil 81:1162-1165.
15. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, Medicis R (1996). Viscosupplementation with Hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada. J Rheumatol 23:1579-1585.
16. McConnell S, Kolopack P, Davis AM (2001). The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Care Res 45:453-461.
17. Messier SP, Loeser RF, Hoover JL, Semble EL,Wise CM (1992). Osteoarthritis of the knee: effects on gait, strength and flexibility. Arch Phys Med Rehabil 73:29-36.
18. Pelletier JP, Martel-Pelletier J (1993). The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as the therapeutic agents in viscosupplementation. J Rheumatol 20 (Suppl 39):19-24.
19. Puttick M, Wade JP, Chalmers A, Connell DG, Rangno RK (1995). Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 22:1311-1314.
20. Roman JA, Chismol J, Morales M, Donderis JL (2000). Intra-articular treatment with hyaluronic acid. Comparative study of Hyalgan and Adant. Clin Rheumatol 19:204-206.
21. Schnitzer TJ, Popovich JM, Andersson GBJ, Andriacchi TP (1993). Effect of piroxicam on gait in patients with osteoarthritis of the knee. Arthritis Rheum 36:1207-1213.
22. Simon LS (1999). Viscosupplementation therapy with intra-articular hyaluronic acid. Rheum Dis Clinics North Am 25:345-357.
23. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, et al. (1999). The role of viscoelasticity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21:1549-1562.